Medical Intelligence Quiz
Challenge Yourself, Build Your Knowledge
Characteristics of essential thrombocythemia
Question 1 of 5
Topics
Multiple Myeloma
Multiple Myeloma
| Quiz | |
|---|---|
| ELOQUENT-3 trial: The addition of IgG monoclonal antibodies to treat multiple myeloma | Take Quiz |
| Multiple myeloma signs, symptoms, and diagnosis | Take Quiz |
| Multiple myeloma: M-proteins & clinical features | Take Quiz |
| Pathological features of multiple myeloma | Take Quiz |
| Multiple myeloma: Genetic factors & risk groups | Take Quiz |
| Multiple myeloma: Initial evaluation | Take Quiz |
| Staging multiple myeloma | Take Quiz |
| Identifying multiple myeloma | Take Quiz |
| Diagnostic criteria for multiple myeloma | Take Quiz |
| Multiple myeloma: Diagnosis, staging, & risk stratification | Take Quiz |
| Pathogenesis of multiple myeloma | Take Quiz |
| Multiple myeloma: Epidemiology & features | Take Quiz |
| Myeloma survival: Post-transplant response and minimal residual disease | Take Quiz |
| Multiple myeloma outcomes: Lower- & higher-volume facilities | Take Quiz |
| Multiple myeloma: MRD & survival | Take Quiz |
| Smoldering multiple myeloma in the United States | Take Quiz |
| Prognosis of multiple myeloma | Take Quiz |
| Plasma cell neoplasms: The basics | Take Quiz |
| Treatment of multiple myeloma | Take Quiz |
| Plasma cell neoplasms: MGUS | Take Quiz |
| Clinical features of multiple myeloma | Take Quiz |
| Diagnosis and staging of multiple myeloma | Take Quiz |
Anemia
Anemia
| Quiz | |
|---|---|
| Paroxysmal nocturnal hemoglobinuria: Management | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Thrombosis | Take Quiz |
| The source of hematopoietic stem cells | Take Quiz |
| Diagnosing paroxysmal nocturnal hemoglobinuria | Take Quiz |
| Signs & symptoms of paroxysmal nocturnal hemoglobinuria | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Prognosis & reducing complications | Take Quiz |
| Overview of hereditary stomatocytosis | Take Quiz |
| Neurological complications in children with sickle cell | Take Quiz |
| Etiology of sideroblastic anemia | Take Quiz |
| Overview of beta-thalassemia | Take Quiz |
| Overview of aplastic anemia | Take Quiz |
| Overview of alpha thalassemia | Take Quiz |
| Signs, symptoms, and staging of iron deficiency anemia | Take Quiz |
| Pathophysiology of iron deficiency anemia | Take Quiz |
| Alpha thalassemia: Management | Take Quiz |
| Types of alpha thalassemia | Take Quiz |
| Alpha thalassemia: Physical findings & diagnosis | Take Quiz |
| Drug-induced hemolysis: Pathophysiology, diagnosis, & treatment | Take Quiz |
| Prognosis & management of megaloblastic anemia | Take Quiz |
| Acute complications of sickle cell disease | Take Quiz |
| Chronic complications of sickle cell disease | Take Quiz |
| Anemia in adults | Take Quiz |
| Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
| Anemia in children | Take Quiz |
| Diagnosis of anemia | Take Quiz |
| Mechanisms of anemia | Take Quiz |
| Drug-induced hemolysis: Clinical features | Take Quiz |
| Diagnosis of megaloblastic anemia | Take Quiz |
Thrombosis
Thrombosis
| Quiz | |
|---|---|
| Paroxysmal nocturnal hemoglobinuria: Management | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Thrombosis | Take Quiz |
| Diagnosing paroxysmal nocturnal hemoglobinuria | Take Quiz |
| Signs & symptoms of paroxysmal nocturnal hemoglobinuria | Take Quiz |
| Paroxysmal nocturnal hemoglobinuria: Prognosis & reducing complications | Take Quiz |
| Vitamin D and thrombosis in systemic lupus | Take Quiz |
| Transitioning from first-line therapies to treat immune thrombocytopenia | Take Quiz |
| Immunoglobulin A-associated vasculitis | Take Quiz |
| Protein C deficiency | Take Quiz |
| Characteristics of polycythemia vera | Take Quiz |
| Diagnosis and treatment of immune thrombocytopenia | Take Quiz |
| Characteristics of essential thrombocythemia | Take Quiz |
| Pathogenesis of immune thrombocytopenia | Take Quiz |
| ISTH Guidance Statement: Identifying & preventing VTE in pediatric cancer | Take Quiz |
| Antiphospholipid antibody syndrome: Diagnosis & management | Take Quiz |
| Thrombotic thrombocytopenic purpura in adults | Take Quiz |
| Hypercoagulable states: Clinical features | Take Quiz |
| ASH Guidelines: Subsequent management of ITP | Take Quiz |
| ASH Guidelines: Initial management of immune thrombocytopenia | Take Quiz |
| ASH Guidelines: Typical features & diagnosis of immune thrombocytopenia | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 1 | Take Quiz |
Bleeding Disorders
Bleeding Disorders
| Quiz | |
|---|---|
| The source of hematopoietic stem cells | Take Quiz |
| von Willebrand disease: Epidemiology & clinical features | Take Quiz |
| Transitioning from first-line therapies to treat immune thrombocytopenia | Take Quiz |
| Solid organ transplantation for sickle cell disease | Take Quiz |
| Factor V resistance to activated protein C | Take Quiz |
| Pathophysiology of disseminated intravascular coagulopathy | Take Quiz |
| Immunoglobulin A-associated vasculitis | Take Quiz |
| Hematopoietic stem-cell transplantation for sickle-cell disease | Take Quiz |
| Secondary iron overload | Take Quiz |
| Characteristics of polycythemia vera | Take Quiz |
| Diagnosis and treatment of immune thrombocytopenia | Take Quiz |
| Pathophysiology of hemophilia | Take Quiz |
| Hereditary hemorrhagic telangiectasia | Take Quiz |
| Forms of Von Willebrand disease | Take Quiz |
| Sickle cell disease: Acute exacerbations | Take Quiz |
| Sickle cell disease: Diagnosis & management | Take Quiz |
| Sickle cell disease: Signs, symptoms, & diagnosis | Take Quiz |
| Thrombotic thrombocytopenic purpura in adults | Take Quiz |
| Hypercoagulable states: Clinical features | Take Quiz |
| Pancytopenia: Patient history & features | Take Quiz |
| Sickle cell trait & HBA1c in African Americans | Take Quiz |
| Hemophilia A and B: Characteristics & diagnosis | Take Quiz |
| Sickle cell trait, rhabdomyolysis, and mortality | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
| Classification of von Willebrand disease | Take Quiz |
| Treatment of von Willebrand disease | Take Quiz |
| Pathophysiology of hemophilia A and B | Take Quiz |
| Clinical manifestations of hemophilia | Take Quiz |
| GVHD: Laboratory & imaging studies | Take Quiz |
CML
CML
| Quiz | |
|---|---|
| Chronic myeloid leukemia: Management | Take Quiz |
| Chronic myeloid leukemia: Symptoms & diagnosis | Take Quiz |
| Overview of chronic myelogenous leukemia | Take Quiz |
| CML: TKI adherence | Take Quiz |
Indolent Lymphoma
Indolent Lymphoma
| Quiz | |
|---|---|
| Risk factors for developing marginal zone lymphoma | Take Quiz |
| Waldenstrom’s macroglobulinemia: Prevalence, features, & diagnosis | Take Quiz |
| Characteristics of splenic marginal zone lymphoma | Take Quiz |
| Transformation of follicular lymphoma | Take Quiz |
| Clinical features of chronic lymphocytic leukemia | Take Quiz |
| Clinical features of mycosis fungoides and Sézary syndrome | Take Quiz |
| Overview of mantle cell lymphoma | Take Quiz |
| mSMART Guidelines: Diagnosis & causes of Waldenstrom macroglobulinemia | Take Quiz |
| Overview of chronic lymphocytic leukemia | Take Quiz |
| About Waldenstrom macroglobulinemia | Take Quiz |
| Subtypes of marginal zone lymphoma | Take Quiz |
| Subtypes of indolent lymphoma | Take Quiz |
| Mycosis fungoides: Early stages & treatment | Take Quiz |
| Nodal marginal zone lymphoma: Epidemiology & clinical presentation | Take Quiz |
| Splenic marginal zone lymphoma: Features, diagnosis, & management | Take Quiz |
| Indolent B-cell lymphoma: Autologous & allogeneic stem cell transplantation | Take Quiz |
| Waldenström’s macroglobulinemia & stem cell transplantation | Take Quiz |
| Characteristics across indolent NHL subtypes | Take Quiz |
| Mycosis fungoides: Clinical presentation, prognosis, & survival | Take Quiz |
| A subset of indolent lymphomas: Features & outcomes | Take Quiz |
| Waldenstrom’s macroglobulinemia: Prognostic factors | Take Quiz |
| Mass cytometry study of follicular lymphoma tumors reveals cellular characteristics | Take Quiz |
| Cutaneous B-cell lymphoma: Epidemiology & diagnosis | Take Quiz |
| Marginal zone lymphoma & primary cutaneous anaplastic large cell lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Marginal zone lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Lymphoplasmacytic lymphoma | Take Quiz |
| Indolent lymphoma subtypes: Follicular lymphoma | Take Quiz |
| Waldenström macroglobulinemia: Symptoms & criteria for treatment | Take Quiz |
Mixed Topics
Mixed Topics
| Quiz | |
|---|---|
| Update on the management of chronic neutrophilic leukemia | Take Quiz |
| Rosai-Dorfman disease | Take Quiz |
| Lymphocytopenia: Signs & symptoms, diagnosis, & treatment | Take Quiz |
| Causes of lymphocytopenia | Take Quiz |
| Cancer survivors: Medication use for anxiety & depression | Take Quiz |
Myelodysplastic Syndrome
Myelodysplastic Syndrome
| Quiz | |
|---|---|
| Managing Ph-positive acute lymphoblastic leukemia | Take Quiz |
| Myelodysplastic syndrome: Diagnosis, risk-stratification, and management | Take Quiz |
| Chronic myelomonocytic leukemia: Diagnosis & management | Take Quiz |
| Myelodysplatic syndrome risk and survival | Take Quiz |
| Etiology of sideroblastic anemia | Take Quiz |
| Pathophysiology of myelodysplastic syndrome | Take Quiz |
| Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
| Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
| Chronic myelomonocytic leukemia: Survival after transplant | Take Quiz |
ALL (Acute Lymphoblastic Leukemia)
ALL (Acute Lymphoblastic Leukemia)
| Quiz | |
|---|---|
| Managing Ph-positive acute lymphoblastic leukemia | Take Quiz |
| Acute leukemia: Initial diagnostic workup | Take Quiz |
| Guidelines: Diagnostic workup of acute leukemia | Take Quiz |
| NCHS Report: Pediatric cancer rates | Take Quiz |
| Ph-like ALL in adults | Take Quiz |
| Acute leukemia: Epidemiology & pathophysiology | Take Quiz |
| Clinical signs & symptoms of acute leukemia | Take Quiz |
| Initial management & tumor lysis syndrome in acute leukemia | Take Quiz |
AML
AML
| Quiz | |
|---|---|
| FDA Approval: Oral small molecule inhibitor for AML patients | Take Quiz |
| Remission and recurrence of adult AML | Take Quiz |
| Treatment of neutropenia | Take Quiz |
| Types of neutropenia | Take Quiz |
| Neutropenia etiology | Take Quiz |
| AML prognosis & survival | Take Quiz |
| Classification of adult AML | Take Quiz |
| Clonal hematopoiesis & risk for therapy-related cancer | Take Quiz |
| AML: Androgen maintenance therapy & survival | Take Quiz |
| Leukemia: Survival after cord-blood transplant | Take Quiz |
| Telomere length and delayed bone marrow recovery in pediatric AML | Take Quiz |
| Extramedullary disease & AML survival | Take Quiz |
Transfusion Medicine
Transfusion Medicine
| Quiz | |
|---|---|
| Bacterial contamination of platelets | Take Quiz |
| ASCO Guideline Update: Platelet transfusion for patients with cancer | Take Quiz |
| Secondary iron overload | Take Quiz |
| Adverse effects of RBC transfusion | Take Quiz |
| Plasma exchange in therapeutic apheresis | Take Quiz |
| Therapeutic uses of cytapheresis | Take Quiz |
| RBC transfusion | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| Platelet transfusion for GI bleeding in patients on antiplatelet agents | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| Transfusion: Age of blood & mortality | Take Quiz |
Clinical Guidelines
Clinical Guidelines
| Quiz | |
|---|---|
| ASCO Guideline Update: Platelet transfusion for patients with cancer | Take Quiz |
| Hydroxyurea & transfusion therapy for sickle cell disease | Take Quiz |
| MGUS risk & diagnosis | Take Quiz |
| Complications of sickle cell disease | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
| ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
| Acute complications of sickle cell disease | Take Quiz |
| Chronic complications of sickle cell disease | Take Quiz |
| Hydroxyurea & transfusion therapy in sickle cell disease | Take Quiz |
Hematology
Hematology
| Quiz | |
|---|---|
| ASCO Guideline Update: Platelet transfusion for patients with cancer | Take Quiz |
| MGUS risk & diagnosis | Take Quiz |
| Cochrane Review: Red blood cell transfusion strategies | Take Quiz |
| Guideline: Antithrombotic therapy for VTE, Part 2 | Take Quiz |
| ASBMT Guidelines: Autologous progenitor cell transplant | Take Quiz |
| AABB Guidelines: RBC transfusion thresholds & storage | Take Quiz |
| ASBMT Guidelines: Autologous & allogeneic HCT considerations in special populations & comorbidities | Take Quiz |
| ASBMT Guidelines: Allogeneic progenitor cell transplant | Take Quiz |
| NHF Guideline: Hemophilia care models | Take Quiz |
Cellular Therapy
Cellular Therapy
| Quiz | |
|---|---|
| Solid organ transplantation for sickle cell disease | Take Quiz |
| Hematopoietic stem-cell transplantation for sickle-cell disease | Take Quiz |
| Hematopoietic stem cell transplantation | Take Quiz |
| Prognostic value of hematopoietic cell transplant comorbidity index | Take Quiz |
| Myelodysplastic syndrome: Genetic mutations & outcomes | Take Quiz |
| HSC donors & health-related quality of life | Take Quiz |
| HSCT outcomes & vancomycin-resistant enterococcus colonization & bacteremia | Take Quiz |
| Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
Hodgkin Lymphoma
Hodgkin Lymphoma
| Quiz | |
|---|---|
| Pathophysiology of Hodgkin lymphoma | Take Quiz |
Patient & Survivor Care
Patient & Survivor Care
| Quiz | |
|---|---|
| Treatment of neutropenia | Take Quiz |
| Types of neutropenia | Take Quiz |
| Neutropenia etiology | Take Quiz |
T Cell Lymphomas
T Cell Lymphomas
| Quiz | |
|---|---|
| Physical findings of mycosis fungoides | Take Quiz |
Aggressive Lymphomas
Aggressive Lymphomas
| Quiz | |
|---|---|
| Double-hit lymphomas: Outcomes after ASCT | Take Quiz |
| HCV: Increased non-Hodgkin lymphoma risk? | Take Quiz |
| Non-Hodgkin lymphoma risk & HIV-Hepatitis coinfection | Take Quiz |
CLL
CLL
| Quiz | |
|---|---|
| CLL & minimal residual disease status | Take Quiz |
| CLL, genetic aberrations, & the elderly | Take Quiz |
| Molecular prognostic indicators in CLL | Take Quiz |
| CLL management & prognosis | Take Quiz |
| Diagnosis, classification, & prognostic factors of CLL | Take Quiz |
| CLL: Risk factors & prognostic factors | Take Quiz |
| Staging CLL | Take Quiz |
| Treatment of CLL | Take Quiz |
| Understanding CLL | Take Quiz |
| CLL: Risk factors & epidemiology | Take Quiz |
| Understanding familial CLL | Take Quiz |
| Clinical manifestations of CLL | Take Quiz |
| Diagnosis of CLL | Take Quiz |
Mantle Cell Lymphoma
Mantle Cell Lymphoma
| Quiz | |
|---|---|
| MCL: Epidemiology, subtypes, & diagnosis | Take Quiz |
| MCL: Diagnosis, treatment, & prognosis | Take Quiz |
| Quiz | |
|---|---|
| Transformed indolent lymphoma and ASCT | Take Quiz |
| Genes & AML | Take Quiz |
| ALL outcomes in pediatric patients | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 2 | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 1 | Take Quiz |
| Classification of adult ALL | Take Quiz |
| HIV-related lymphomas and AHCT | Take Quiz |
| Adult HL treatment | Take Quiz |
| Diagnosis and assessment of ALL | Take Quiz |
| Guideline updates for non-Hodgkin lymphomas: Part 3 | Take Quiz |
| Staging of adult HL | Take Quiz |
| Treatment of adult ALL | Take Quiz |
Lymphoma & Plasma Cell Disorders
Lymphoma & Plasma Cell Disorders
| Quiz | |
|---|---|
| Treatment of adult HL | Take Quiz |
| Diagnosis & pathogenesis of primary CNS lymphoma | Take Quiz |
| Indolent & aggressive NHL | Take Quiz |
| Cellular classification & treatment of NHL | Take Quiz |
| Understanding NHL | Take Quiz |
| Prognosis of primary CNS lymphoma | Take Quiz |